Results 61 to 70 of about 9,597 (210)
Health Science Reports, Volume 9, Issue 6, June 2026.ABSTRACT Background and Aim The Democratic Republic of the Congo (DRC) is among the countries most affected by cholera in the world. Since the 1970s, endemic foci have persisted in the eastern lake provinces, where chronic armed conflict, massive population displacement, and extreme socioeconomic inequalities create particularly favorable conditions ...
Hermann Yokolo +4 more
wiley +1 more source
Licensed and Recommended Inactivated Oral CholeraVaccines: From Development to Innovative Deployment
Tropical Medicine and Infectious Disease, 2021 Cholera is a disease of poverty and occurs where there is a lack of access to clean water and adequate sanitation. Since improved water supply and sanitation infrastructure cannot be implemented immediately in many high-risk areas, vaccination against ...
Jacqueline Deen, John D. Clemens
doaj +1 more source
Pharmacy‐Based Immunization Delivery: A Comprehensive History and Current Challenges
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 6, June 2026.ABSTRACT Pharmacists and their teams have a long history of involvement with vaccines. This paper describes the contributions of pharmacy‐based immunization delivery in the United States from the 1800's to date. Early activities centered around storage and distribution of antitoxins and vaccines. From the 1950s through the early 1990s, pharmacists were
Jean‐Venable R. Goode +4 more
wiley +1 more source
Single-Dose Oral Cholera Vaccine in Bangladesh [PDF]
New England Journal of Medicine, 2016 To the Editor: The reported 6-month efficacy of a single dose of oral cholera vaccine in Bangladesh (May 5 issue),1 although seemingly modest, may have profound implications for future use of the vaccine. One-year protection from two doses in India and Bangladesh did not differ significantly from these new results, a finding that suggests that short ...
Andrew S, Azman, Francisco J, Luquero
openaire +2 more sources
PLoS Neglected Tropical Diseases, 2016 BackgroundUse of the oral cholera vaccine (OCV) is a vital short-term strategy to control cholera in endemic areas with poor water and sanitation infrastructure.
Vittal Mogasale +3 more
doaj +1 more source
Production of putative enhanced oral cholera vaccine strains that express toxin-coregulated pilus. [PDF]
PLoS ONE, 2017 The use of whole cell killed (WCK) oral cholera vaccines is an important strategy for cholera prevention in endemic areas. To overcome current vaccine limitations, we engineered strains of V.
Caitlyn A Hauke, Ronald K Taylor
doaj +1 more source
Bakteriopolis: Introducing Microbes to Society
Microbial Biotechnology, Volume 19, Issue 6, June 2026.Bakteriopolis is a travelling exhibition that brings the invisible microbial world into public spaces. The project is accompanied by a broad communication strategy to engage diverse audiences. ABSTRACT Microorganisms, while being fundamental to life on Earth, are often associated with negative perceptions and global crises.
Lena Friebel +2 more
wiley +1 more source
Process for oral cholera vaccine deployment. [PDF]
, 2014 Process for oral cholera vaccine deployment.
Dang Duc Anh (232106) +8 more
core +1 more source
PLoS Neglected Tropical Diseases, 2016 BackgroundThe bivalent whole-cell (BivWC) oral cholera vaccine (Shanchol) is effective in preventing cholera. However, evaluations of immune responses following vaccination with BivWC have been limited.
Wilfredo R Matias +11 more
doaj +1 more source
Food Science &Nutrition, Volume 14, Issue 5, May 2026.Natural Extracts as Candidate Influenza Vaccine Adjuvants. Seasonal influenza vaccines face limitations due to viral mutations and low efficacy in vulnerable populations. Traditional adjuvants often have safety or immune‐activation constraints, leading to increased interest in natural extracts from plants, marine organisms, and fungi.
Thi Len Ho, Eun‐Ju Ko
wiley +1 more source